Table 1 Patient baseline characteristics, International Prostate Symptom Score (IPSS) and urodynamic parameters.
Total (n = 94) | DU (n = 24) | Non-DU (n = 70) | p | |
|---|---|---|---|---|
Baseline, median (IQR) | ||||
Age, yr | 71 (66–75) | 73 (70.5–75.5) | 71 (66–74) | 0.056 |
BMI, kg/m2 | 24.0 (22.8–25.4) | 23.3 (22.3–24.9) | 24.1 (22.9–25.5) | 0.356 |
DM, n (%) | 27 (28.7%) | 10 (41.7%) | 17 (24.3%) | 0.247 |
HTN, n (%) | 50 (53.2%) | 14 (58.3%) | 36 (51.4%) | 0.550 |
CVA, n (%) | 6 (6.4%) | 2 (8.3%) | 4 (5.7%) | 0.742 |
PSA, ng/ml | 3.50 (1.43–6.62) | 3.31 (1.62–5.67) | 3.56 (1.41–7.36) | 0.352 |
TRUS, mL | 48 (39–73) | 43 (35–47) | 55 (40–83) | 0.297 |
Questionnaire | ||||
IPSS total | 20 (12–29) | 21 (11–25) | 19 (12–29) | 0.874 |
IPSS voiding | 12 (6–17) | 15 (6–17) | 12 (7–17) | 0.859 |
IPSS storage | 8 (5–11) | 7 (5–9) | 8 (5–11) | 0.488 |
OABSS | 5 (4–8) | 7 (4–9) | 5 (4–8) | 0.786 |
Urodynamics, mean ± SD | ||||
Free Qmax, mL/s | 8.9 ± 4.2 | 8.3 ± 4.1 | 9.1 ± 4.3 | 0.522 |
Free VV, mL | 161.3 ± 93.9 | 143.6 ± 106.0 | 166.8 ± 90.4 | 0.423 |
Free PVR, mL | 88.3 ± 88.1 | 93.7 ± 81.1 | 86.6 ± 91.1 | 0.789 |
First desire to void, mL | 175.9 ± 76.9 | 191.4 ± 84.3 | 170.8 ± 74.7 | 0.375 |
Normal desire to void, mL | 254.9 ± 99.7 | 255.5 ± 78.4 | 254.8 ± 106.6 | 0.979 |
Strong desire to void, mL | 333.6 ± 100.4 | 349.5 ± 81.4 | 328.3 ± 106.3 | 0.349 |
MCC, mL | 336.2 ± 97.9 | 349.5 ± 81.4 | 331.8 ± 103.3 | 0.548 |
Compliance, mL/cmH2O | 50.9 ± 36.5 | 48.1 ± 39.3 | 51.9 ± 35.9 | 0.728 |
IDC ( +), n (%) | 66 (70.2%) | 18 (75.0%) | 48 (68.6%) | 0.745 |
IDC terminal, n (%) | 31 (33.0%) | 10 (41.7%) | 21 (30.0%) | 0.527 |
PdetQmax, cmH2O | 59.3 ± 26.6 | 35.8 ± 6.7 | 67.3 ± 26.2 | < 0.001 |
Opening Pressure, cmH2O | 57.3 ± 33.3 | 34.2 ± 13.3 | 65.2 ± 34.5 | < 0.001 |
BOOI | 44.9 ± 28.0 | 22.7 ± 6.3 | 52.8 ± 28.3 | < 0.001 |
BCI | 92.3 ± 30.7 | 69.1 ± 21.0 | 100.1 ± 29.7 | < 0.001 |
BVE | 62.2 ± 25.2 | 52.9 ± 29.5 | 65.4 ± 23.1 | 0.102 |
